Scandinavian Tobacco Group (STG) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
14 Sep, 2026Opening remarks and agenda
The meeting was convened in accordance with legal and statutory requirements, with English as the official language and Danish summaries provided.
The agenda included financial review, adoption of the annual report, profit appropriation, remuneration, board elections, auditor appointment, shareholder proposals, and other business.
Financial performance review
Net sales reached DKK 9.2 billion in 2024, a record high and a 5% increase from 2023.
EBITDA before special items was DKK 2.1 billion, with a margin of 22.6%, down from 24.1% in 2023.
Free cash flow before acquisitions was DKK 931 million, a 12% decrease year-over-year.
Adjusted earnings per share was DKK 13.7.
2025 outlook projects net sales of DKK 9.2–9.7 billion and EBITDA margin of 20–23%.
Sales growth was driven by the Mac Baren acquisition and growth enablers, despite margin pressure from investments and market challenges.
All three commercial divisions reported sales growth, with online and retail channels in North America showing double-digit growth.
Dividend announcements
Proposed dividend of DKK 8.5 per share for 2024, up from DKK 8.4 in 2023, totaling DKK 731 million.
Share buyback program of DKK 850 million completed, with total capital return close to DKK 1.5 billion in 2024.
Shareholder return policy remains unchanged, focusing on annual dividend growth and potential share buy-backs.
Latest events from Scandinavian Tobacco Group
- 2025 saw lower earnings and a new strategy focused on cigars, nicotine pouches, and sustainability.STG
AGM 2026 presentation - Stable margins and cash flow in H1 2026; divestment enhances flexibility and guidance is maintained.STG
Q2 2026 - Stable margins and cash flow amid 6% sales decline; handmade cigars up 8% organically.STG
Q1 2026 - 2025 results declined, but Focus2030 and strong cash flow support a stable 2026 outlook.STG
Q4 2025 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 2025 - Q3 net sales up 7.1% on Mac Baren deal; EBITDA margin and organic growth declined.STG
Q3 2024 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 2024 - Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 2025 - Net sales up 5.4% to DKK 9.2bn, but profit down 20.5% amid margin pressure and investments.STG
Q4 2024